DeutschNewstral
Article
bizjournals.com on 2019-12-20 12:00
Federal tax repeal equals research boost, more stability for AngioDynamics
Related news
- AngioDynamics' latest acquisition will boost $95 million business linebizjournals.com
- AngioDynamics pushes through pandemic with no layoffs and more research spendingbizjournals.com
AngioDynamics hails tax freezepoststar.com- AngioDynamics secures $100 million loanbizjournals.com
- Tech camp students tour AngioDynamicspoststar.com
- AngioDynamics acquires Israeli laser startupbizjournals.com
- AngioDynamics' CFO will leave companybizjournals.com
- AngioDynamics licenses microsphere treatment technologybizjournals.com
- AngioDynamics expands oncology business with RadiaDyne acquisitionbizjournals.com
- AngioDynamics sells manufacturing plant for $5.75 millionbizjournals.com
- AngioDynamics projects solid sales growth in 2016bizjournals.com
- AngioDynamics' bold move: get smaller (for now)bizjournals.com
- AngioDynamics eliminates top oncology job, overhauls unitbizjournals.com
- BNew Research: Hiking Equals Healthblueridgecountry.com
- AngioDynamics expands oncology business with acquisition of Houston co.bizjournals.com
- Oncology business propels AngioDynamics to $91.5 million second quarterbizjournals.com
- AngioDynamics slows spending as hospitals delay elective surgeries amid coronavirusbizjournals.com
- AngioDynamics will pay $12.5 million to resolve false claims casebizjournals.com
- Deal positions AngioDynamics to re-enter $150 million marketbizjournals.com
- AngioDynamics will sell Namic business for $167.5 millionbizjournals.com